Every few months you hear that Ozempic is out of stock. Here's why the supply is so tight — and what alternatives are available.
Global demand spike
Off-label weight-loss demand globally has 5–10×'d in three years. Novo Nordisk has been adding manufacturing capacity but lead times for biologics are years, not weeks.
India-specific issues
Cold-chain logistics constrain how fast pens can be distributed to tier-2 and tier-3 cities. Some pharmacies hold limited stock; allocation favours metro patients.
When you can't get Ozempic
Switch to Wegovy (same molecule, weight indication, often better in stock). Or to Mounjaro (different molecule, generally more available). Your doctor can switch and re-titrate.
How we plan around it
ZIVOLABS dispatches a one-month supply with each cycle. If your assigned pharmacy is low, we re-route to a partner with stock — you don't experience a gap.
